B Ibanez, A Fernández-Ortiz, L Fernández-Friera… - Journal of the American …, 2021 - jacc.org
Atherosclerosis starts early in life and progresses silently for decades. Considering atherosclerosis as a “systemic disease” invites the use of noninvasive methodologies to …
S Raposeiras-Roubin, X Rosselló, B Oliva… - Journal of the American …, 2021 - jacc.org
Background Even when low-density lipoprotein-cholesterol (LDL-C) levels are lower than guideline thresholds, a residual risk of atherosclerosis remains. It is unknown whether …
Background: Sleep duration and quality have been associated with increased cardiovascular risk. However, large studies linking objectively measured sleep and …
VG de Yébenes, AM Briones… - … , and vascular biology, 2020 - Am Heart Assoc
Objective: microRNAs are master regulators of gene expression with essential roles in virtually all biological processes. miR-217 has been associated with aging and cellular …
E Colonnello, G Ciocca, E Limoncin, A Sansone… - Nature Reviews …, 2021 - nature.com
Premature ejaculation (PE) and poor ejaculatory control are multidimensional sexual symptoms estimated to affect almost one-third of men, severely impairing the overall quality …
F Alameri, N Aldaheri, S Almesmari… - Frontiers in …, 2022 - frontiersin.org
Introduction The objective of this study was to investigate the psychosocial and cardiovascular markers in healthcare professionals during the COVID-19 pandemic …
ED Michos, SS Khan - Expert review of cardiovascular therapy, 2021 - Taylor & Francis
ABSTRACT Introduction The American Heart Association (AHA) introduced the construct of 'cardiovascular health (CVH)', to focus on primordial prevention to reduce the burden of …
I Garcia-Lunar, HP van der Ploeg… - European heart …, 2022 - academic.oup.com
Aims To investigate the effectiveness of a 3-year worksite lifestyle intervention on cardiovascular metrics and to study whether outcomes are influenced by baseline …
F Barkas, YZ Sener, PA Golforoush, A Kheirkhah… - Atherosclerosis, 2024 - Elsevier
Atherosclerotic cardiovascular disease (ASCVD) remains a leading cause of morbidity and mortality worldwide, highlighting the urgent need for advancements in risk assessment and …